Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial
Titel:
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial
Auteur:
Murialdo, R. Bertolotti, F. Pastorino, G. Mencoboni, M. Bergaglio, M. Folco, U. Cinzia, N. Vaira, F. Simoni, C. Canobbio, L. Parodi, M. Brema, Fulvio Ballestrero, Alberto